A detailed history of Jefferies Financial Group Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 300 shares of GH stock, worth $8,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$8,688
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $6,690 - $10,887
300 New
300 $6,000
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $481,909 - $1.13 Million
18,943 New
18,943 $515,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.96B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.